User profiles for Zachary Morris

Zachary Morris

- Verified email at stonybrook.edu - Cited by 380

Zachary S. Morris

- Verified email at yale.edu - Cited by 294

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

…, B Bednarz, PM Sondel, J Weichert, ZS Morris - Science translational …, 2021 - science.org
Molecular and cellular effects of radiotherapy on tumor microenvironment (TME) can help
prime and propagate antitumor immunity. We hypothesized that delivering radiation to all …

[HTML][HTML] NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy

W Wang, AK Erbe, JA Hank, ZS Morris… - Frontiers in …, 2015 - frontiersin.org
Natural killer (NK) cells play a major role in cancer immunotherapies that involve tumor-antigen
targeting by monoclonal antibodies (mAbs). NK cells express a variety of activating and …

Development of an in situ cancer vaccine via combinational radiation and bacterial‐membrane‐coated nanoparticles

…, R Sriramaneni, KM Kim, S Gong, ZS Morris - Advanced …, 2019 - Wiley Online Library
Neoantigens induced by random mutations and specific to an individual's cancer are the
most important tumor antigens recognized by T cells. Among immunologically “cold” tumors, …

Heterochronic shifts and conserved embryonic shape underlie crocodylian craniofacial disparity and convergence

ZS Morris, KA Vliet, A Abzhanov… - Proceedings of the …, 2019 - royalsocietypublishing.org
The distinctive anatomy of the crocodylian skull is intimately linked with dietary ecology,
resulting in repeated convergence on blunt- and slender-snouted ecomorphs. These …

Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology

…, M McCarter, SV McGarry, C Meyer, ZS Morris… - Journal of the National …, 2018 - jnccn.org
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, …

[HTML][HTML] Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?

S Demaria, C Guha, J Schoenfeld, Z Morris… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Recent evidence indicates that ionizing radiation can enhance immune responses to tumors.
Advances in radiation delivery techniques allow hypofractionated delivery of conformal …

[HTML][HTML] The promise of combining radiation therapy with immunotherapy

JC Jagodinsky, PM Harari, ZS Morris - International Journal of Radiation …, 2020 - Elsevier
The development of immunotherapy in oncology builds upon many years of scientific
investigation into the cellular mechanics underlying interactions between tumor cells and immune …

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments

ZS Morris, EI Guy, DM Francis, MM Gressett… - Cancer research, 2016 - AACR
Interest in combining radiotherapy and immune checkpoint therapy is growing rapidly. In
this study, we explored a novel combination of this type to augment antitumor immune …

[HTML][HTML] Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade

…, PM Sondel, K Kim, S Gong, ZS Morris - Nature …, 2022 - nature.com
Radiation therapy (RT) activates an in situ vaccine effect when combined with immune checkpoint
blockade (ICB), yet this effect may be limited because RT does not fully optimize tumor …

A molecular mechanism for the origin of a key evolutionary innovation, the bird beak and palate, revealed by an integrative approach to major transitions in vertebrate …

BAS Bhullar, ZS Morris, EM Sefton, A Tok, M Tokita… - …, 2015 - academic.oup.com
The avian beak is a key evolutionary innovation whose flexibility has permitted birds to
diversify into a range of disparate ecological niches. We approached the problem of the …